- Global Pharma News & Resources

Drägerwerk AG & Co. KGaA: Dräger with strong order entry in the first quarter

Drägerwerk AG & Co. KGaA / Key word(s): Incoming Orders/Development of Sales
Drägerwerk AG & Co. KGaA: Dräger with strong order entry in the first quarter

09-Apr-2020 / 17:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ad-hoc notification in accordance with Sec. 17 of the MAR

Drägerwerk AG & Co. KGaA: Dräger with strong order entry in the first quarter

Dräger's order intake in the first quarter of fiscal 2020 soared compared to the first quarter of last year in the context of the Covid-19 Pandemic. The order intake in Q1 amounted to around EUR 1,393 mn. (Q1 2019: EUR 648 mn.), 117% (net of currency effects) above the level a year ago. The demand in the medical division is currently particularly high. Orders in the medical division were around EUR 1,043 mn. (Q1 2019: EUR 376 mn.) which is an increase of around 179% (net of currency effects) compared to same period a year ago. Orders in the safety division rose by around 31% (net of currency effects) to around EUR 349 mn. (Q1 2019: EUR 271 mn.).

Net sales so far benefited only to a smaller degree from the high order intake. Net sales in the first quarter amounted to around EUR 640 mn. (Q1 2019: EUR 602 mn.) which is around 7.1 % (net of currency effects) above the level a year ago. Earnings figures for the first quarter are not available yet.

The preliminary result for the first quarter 2020 should be available for publication towards the end of next week.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998

This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at for information on alternative performance measures used.

09-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: SDAX, TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1019703

End of Announcement DGAP News Service

Editor Details

Last Updated: 09-Apr-2020